Advertisement
Cardiovascular
Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Anticoagulation Published

January 20, 2014 12:41 pm | by Business Wire | News | Comments

EKOS Corporation, a BTG International group company, located in Bothell, Washington in the United States, today announced the publication of the results of its Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (PE) trial (ULTIMA) in...

New Energy Harvesting Technology Set to Reduce Number of Open-Heart Surgeries

January 20, 2014 12:30 pm | by University of Waterloo | News | Comments

Researchers at the University of Waterloo have developed a new technology that could dramatically reduce the number of open-heart surgeries for people with pacemakers. Professor Armaghan Salehian’s research group has developed wideband...

Cardialen brings in close to $3M

January 20, 2014 12:29 pm | by Mass Device | News | Comments

Cardialen is closing in on a $4 million equity round, after raising $2.5 million from 18 unnamed investors. Minneapolis and St. Louis-based Cardialen is developing a low-energy implant for atrial fibrillation designed to control the fibrillation...

Advertisement

Ceram Leads Project to Develop New Biomaterials and New Arterial Stents

January 20, 2014 10:19 am | by Ceram | News | Comments

As coordinator of the European project ‘ReBioStent’, Ceram, the international materials technology company, is pleased to announce that the project, to develop new biomaterials and new arterial stents, has been awarded Euro 5.874M by the...

Global Telehealth Market Set to Expand Tenfold by 2018

January 17, 2014 12:15 pm | by IHS Technology | News | Comments

The global telehealth market is expected to grow by more than a factor of 10 from 2013 to 2018, as medical providers increasingly employ remote communications and monitoring technology to reduce costs and improve the quality of care, according...

CEA Joins Industry Groups in Sponsoring Educational Series on Health App Development Under FDA Regulation

January 17, 2014 11:53 am | by Consumer Electronics Association | News | Comments

Today, the Consumer Electronics Association announced its sponsorship of an educational program series called the “Mobile Medical Apps (MMA) Roadshow: Managing App Development under FDA Regulation,” joining a consortium of six leading... 

Silver Nanowire Sensors Hold Promise for Prosthetics, Monitoring

January 17, 2014 11:26 am | by North Carolina State University | News | Comments

North Carolina State University researchers have used silver nanowires to develop wearable, multifunctional sensors that could be used in biomedical, military or athletic applications, including new prosthetics, robotic systems and flexible...

Medtronic CoreValve System Obtains Early FDA Approval on Exceptional Clinical Performance

January 17, 2014 11:17 am | by The Associated Press | News | Comments

Medtronic today announced the U.S. Food and Drug Administration approval of the self-expanding transcatheter CoreValve System for severe aortic stenosis patients who are too ill or frail to have their aortic valves replaced through traditional...

Advertisement

Immune Cells May Heal an Injured Heart

January 17, 2014 11:00 am | by Julia Evangelou Strait, Washington University in St. Louis | News | Comments

The immune system plays an important role in the heart’s response to injury. But until recently, confusing data made it difficult to distinguish the immune factors that encourage the heart to heal following a heart attack, for example... 

New Method to Detect Key Indicator of Heart Diseases

January 17, 2014 10:47 am | by Dartmouth College | News | Comments

A team that includes Dartmouth College researchers has discovered a new way to detect cardiolipin, a key indicator of heart diseases and some genetic disorders. The results, which appear in the journal Analytical Chemistry, may eventually...

Renal denervation is 'highly unlikely,' says Medtronic study insider

January 16, 2014 6:13 pm | by Mass Device | News | Comments

The future of renal denervation in treatment of hypertension is shaky at best, according to one of the principal investigators involved with Medtronic's disappointing clinical trial. Despite continued optimism from some of medtech's biggest players...

Wireless Electronic Home Healthcare for All

January 16, 2014 3:20 pm | by Sean Fenske, Editor-in-Chief | Texas Instruments Inc., Analog Devices, Inc., Ximedica | Articles | Comments

These days, it’s as though the medical device industry is more synonymous with the electronics industry than it is with healthcare. Obviously an exaggeration, but there seems to be very few device sectors where electronics are not an integral...

Multi Parameter Hospital and Cardiac Patient Monitoring Market 2019 Shares Strategies and Forecast

January 16, 2014 3:16 pm | by PR Newswire | News | Comments

The study on Hospital Patient Multi - Parameter Monitors Market has 230 pages, 102 tables and figures. Whereas cardiac monitor units were initially used in newly created critical care units, now many patients with primary disease conditions...

Advertisement

Infraredx Announces Nipro Corporation’s Plans for Commercial Manufacturing of TVC Imaging System in Japan

January 16, 2014 12:00 pm | by The Associated Press | News | Comments

Infraredx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery disease, today announced that Nipro Corporation, the exclusive distributor of the TVC Imaging System in Japan, has established...

CorMatrix Cardiovascular Receives U.S. Patent for Injectable Biomaterial

January 16, 2014 11:30 am | by Business Wire | News | Comments

CorMatrix Cardiovascular, Inc., a leading medical device developer, today announced the issuance of U.S. Patent No. 8,568,761 for an augmented injectable extracellular matrix (ECM) bioscaffold. The augmented ECM bioscaffold induces stem cell...

Jury says Medtronic owes Edwards about $390M

January 16, 2014 11:24 am | by The Associated Press | News | Comments

A federal jury ruled Wednesday that medical device maker Medtronic infringed on a patent held by Edwards Lifesciences and ordered Medtronic to pay its competitor about $390 million in damages. Edwards said it will seek a permanent injunction...

Option ELITE Retrievable Vena Cava Filter Receives FDA Clearance for an Over-The-Wire Delivery Technique

January 16, 2014 7:22 am | by PR Newswire | News | Comments

Argon Medical Devices, Inc. announced today that the company has received clearance from the US Food and Drug Administration to begin marketing the Option™ELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire delivery...

Medtronic to Appeal Federal District Court Verdict

January 15, 2014 11:58 am | by Medtronic | News | Comments

A jury in the Federal District Court of Delaware today decided in favor of Edwards Lifesciences, ruling that the Medtronic CoreValve® System infringed on Edward's Cribier patent (US Pat. No. 8,002,825). Medtronic intends to appeal. "While...

Remote Follow-Up of Patients with Implantable Defibrillators Significantly Reduces Ambulatory Costs

January 15, 2014 11:45 am | by BIOTRONIK | News | Comments

BIOTRONIK Home Monitoring significantly reduces the cost of follow-up in patients with implantable defibrillators (ICDs). New data from the ECOST (Effectiveness and Cost of ICD Follow-Up Schedule with Telecardiology) study show remote...  

On-X Life Technologies Reports CE Mark Approval to Sell Its Mechanical Aortic Heart Valve

January 15, 2014 9:00 am | by The Associated Press | News | Comments

On-X Life Technologies announced today that its previously CE (Conformité Européenne)-marked On-X Prosthetic Heart Valve has received European regulatory approval for an expanded labeling claim, which now permits the company to market its...

Elixir Medical Announces First Commercial Implant Of The DESolve Novolimus Eluting Coronary Scaffold System in Europe

January 15, 2014 7:00 am | by The Associated Press | News | Comments

Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical’s CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany...

GPOs: Haemonetics inks supply deal with HemeXcel

January 14, 2014 1:44 pm | by Mass Device | News | Comments

Haemonetics signed a 2-year exclusive supply deal with HemeXcel Purchasing Alliance LLC, providing blood collection devices to group purchasing organization HemeXcel's 5 blood centers. Altogether, HemeXcel's sites collect, process, and distribute...

Researchers Investigating How to Make PET Imaging Even Sweeter

January 14, 2014 12:34 pm | by The Mount Sinai Hospital/Mount Sinai School of Medicine | News | Comments

An international research team led by Mount Sinai Heart at Icahn School of Medicine at Mount Sinai, is testing its novel sugar-based tracer contrast agent to be used with positron emission tomography (PET) imaging to help in the hunt for dangerous...

VC Funding in Healthcare IT Sector Reaches New Heights with $2.2 Billion in 2013

January 14, 2014 11:13 am | by Mercom Capital Group | News | Comments

Mercom Capital Group, llc, a global communications and consulting firm, released its annual report on funding and mergers and acquisition (M&A) activity for the Healthcare Information Technology (IT) sector in 2013. Venture capital (VC)...

ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme™ Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease

January 14, 2014 7:35 am | by The Associated Press | News | Comments

ARIAD Pharmaceuticals, Inc. and Medinol, Ltd. today announced the initiation of two registration trials of Medinol’s NIRsupreme TM Ridaforolimus-Eluting Coronary Stent System incorporating ARIAD’s mTOR inhibitor, ridaforolimus. The two NIRsupreme...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading